Profitability
This table compares Moolec Science and Evergreen’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Moolec Science | -140.32% | -119.34% | -25.83% |
Evergreen | N/A | -31.43% | 4.04% |
Earnings and Valuation
This table compares Moolec Science and Evergreen”s revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Moolec Science | $5.44 million | 4.59 | -$7.31 million | ($0.21) | -3.10 |
Evergreen | N/A | N/A | $3.67 million | $0.28 | 42.74 |
Evergreen has lower revenue, but higher earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Evergreen, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
Summary
Evergreen beats Moolec Science on 8 of the 9 factors compared between the two stocks.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
About Evergreen
Evergreen Corporation is a blank check company. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Kuala Lumpur, Malaysia.
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.